As Founder and CEO of Symbiosis, Colin is responsible for the company’s performance and delivery of its strategic business plan and for generating maximum value for all shareholders and stakeholders. He manages all aspects of the company’s day-to-day operations and drives its strategic development efforts.
With over two decades of experience in the life science industry working for small and large biopharma organisations on an international basis, Colin has spent most of his career helping clients overcome drug development challenges within the field of drug development and the sterile manufacture of biopharmaceuticals arena in particular.
Working closely with his management team, Colin ensures the company maintains its client-orientated philosophy and is focussed on the fundamental importance of Quality, and compliance. He oversees the delivery of Symbiosis’ services which enable the success of clients’ projects, the development of long-term relationships, and secure repeat business in a way which is mutually beneficial.
He holds a BSc (Hons) degree in Cell Biology from Glasgow University, an MSc in Molecular Genetics from Glasgow University and an MBA from Strathclyde University specialising in international marketing and strategic relationships.